Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Matrix-Assisted Laser Desorption Ionization (MALDI)01:08

Matrix-Assisted Laser Desorption Ionization (MALDI)

1.0K
Matrix-assisted laser desorption ionization (MALDI) is a powerful analytical technique used in mass spectrometry. It enables the identification and characterization of various biomolecules, including proteins, peptides, nucleic acids, and carbohydrates. MALDI is an ionization technique, widely employed in biological and medical research, as well as in fields like pharmacology and biochemistry.The analyte of interest, a biomolecule or a mixture of biomolecules, is mixed with a suitable matrix...
1.0K
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

6.6K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
6.6K
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

186
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
186
Spin–Spin Coupling: Two-Bond Coupling (Geminal Coupling)01:20

Spin–Spin Coupling: Two-Bond Coupling (Geminal Coupling)

1.6K
Two NMR-active nuclei bonded to a central atom can be involved in geminal or two-bond coupling. Geminal coupling is commonly seen between diastereotopic protons in chiral molecules and unsymmetrical alkenes, among others.
The central atom need not be NMR-active because its electrons are affected by the electron polarization of the spin-active atoms. However, spin information is transmitted less effectively than in one-bond coupling, and 2J values are usually weaker than 1J values. The energy of...
1.6K
Spin–Spin Coupling: Three-Bond Coupling (Vicinal Coupling)01:22

Spin–Spin Coupling: Three-Bond Coupling (Vicinal Coupling)

1.5K
Vicinal or three-bond coupling is commonly observed between protons attached to adjacent carbons. Here, nuclear spin information is primarily transferred via electron spin interactions between adjacent C‑H bond orbitals. This generally favors the antiparallel arrangement of spins, so 3J values are usually positive.
The extent of coupling depends on the C‑C bond length, the two H‑C‑C angles, any electron-withdrawing substituents, and the dihedral angle between the involved orbitals. The...
1.5K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the Fixed Charge: A New On-Tissue Derivatisation Strategy Employing Photoionisable Chromophores for Mass Spectrometry Imaging of Amino-Containing Metabolites.

Angewandte Chemie (International ed. in English)·2026
Same author

YAP1 Knockdown Reduces IL-1β-Induced Human Chondrocyte Inflammation and Promotes Human MSC Chondrogenesis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Dynamic neutrophil lipidome remodeling during induction of NETosis.

Science advances·2026
Same author

Single-Ion Imaging Native Mass Spectrometry: Unraveling the Structural Features and Dissociation Energetics of Macromolecular Assemblies.

Journal of the American Society for Mass Spectrometry·2026
Same author

Spatiotemporal Mapping of Drug Incorporation in Human Nails by MALDI-FTICR-MSI.

Journal of the American Society for Mass Spectrometry·2026
Same author

Isotope Decluttering Reduces Spectral Complexity while Maintaining Protein Structure.

Analytical chemistry·2026

Related Experiment Video

Updated: Jan 21, 2026

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging
09:08

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging

Published on: December 22, 2020

7.1K

Enhanced Sensitivity Using MALDI Imaging Coupled with Laser Postionization (MALDI-2) for Pharmaceutical Research.

Florian P Y Barré1, Martin R L Paine1, Bryn Flinders1

  • 1The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry , Maastricht University , Universiteitssingel 50 , 6229 ER Maastricht , The Netherlands.

Analytical Chemistry
|July 30, 2019
PubMed
Summary

Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) is enhanced by MALDI-2, improving drug detection sensitivity. This novel technique significantly boosts signal intensity, enabling visualization of drug distributions in tissues for pharmaceutical research.

More Related Videos

Preparation of Homogeneous MALDI Samples for Quantitative Applications
08:01

Preparation of Homogeneous MALDI Samples for Quantitative Applications

Published on: October 28, 2016

9.4K
MALDI Sample Preparation: the Ultra Thin Layer Method
05:28

MALDI Sample Preparation: the Ultra Thin Layer Method

Published on: April 29, 2007

20.0K

Related Experiment Videos

Last Updated: Jan 21, 2026

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging
09:08

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging

Published on: December 22, 2020

7.1K
Preparation of Homogeneous MALDI Samples for Quantitative Applications
08:01

Preparation of Homogeneous MALDI Samples for Quantitative Applications

Published on: October 28, 2016

9.4K
MALDI Sample Preparation: the Ultra Thin Layer Method
05:28

MALDI Sample Preparation: the Ultra Thin Layer Method

Published on: April 29, 2007

20.0K

Area of Science:

  • Pharmaceutical analysis
  • Mass spectrometry imaging
  • Analytical chemistry

Background:

  • Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) is crucial for visualizing drug and metabolite distributions in pharmaceutical research.
  • Low ionization efficiency in conventional MALDI-MSI limits the detection of compounds at relevant concentrations.
  • Improving sensitivity is key to expanding the applications of MALDI-MSI in drug development.

Purpose of the Study:

  • To evaluate the efficacy of laser-post-ionization coupled with MALDI (MALDI-2) for analyzing pharmaceutical compounds.
  • To assess the potential of MALDI-2 for enhancing the sensitivity and imaging capabilities of MALDI-MSI.
  • To investigate the ionization mechanism of MALDI-2 in the context of pharmaceutical analysis.

Main Methods:

  • Application of MALDI-2 for the first time to the analysis and imaging of pharmaceutical compounds.
  • Comparison of signal intensities between MALDI-2 and conventional MALDI for ten drug compounds.
  • Visualization of drug distributions in human cartilage and dog liver tissue using both techniques.

Main Results:

  • MALDI-2 increased signal intensities for 7 out of 10 drug compounds by up to two orders of magnitude compared to conventional MALDI.
  • MALDI-2 enabled visualization of drug distributions in human cartilage and dog liver tissue, where conventional MALDI yielded little to no signal.
  • The preferential formation of [M + H]+ ions with MALDI-2 showed no clear correlation with gas-phase proton affinity values.

Conclusions:

  • MALDI-2 significantly enhances sensitivity for pharmaceutical compound analysis using MALDI-MSI.
  • This technique broadens the application scope of mass spectrometry imaging in pharmaceutical research and drug development.
  • The ionization mechanism of MALDI-2 appears complex and warrants further investigation, similar to conventional MALDI.